Willingness to accept the Dengue vaccine among adult Malaysians – An online survey [PDF]
Human Vaccines & ImmunotherapeuticsStudying the willingness to accept a new vaccine helps better understand the consumer behavior to formulate strategies to improve its acceptance when rolled out on a large scale.
Chandrashekhar T. Sreeramareddy +7 more
doaj +2 more sources
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Molecules, 2021 Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue ...
Harun Norshidah +2 more
doaj +3 more sources
Dengue vaccine acceptability in Peru: A mixed-methods study in two dengue-endemic Peruvian cities. [PDF]
PLoS Neglected Tropical DiseasesIntroductionDengue poses a major public health challenge in Peru, with Piura and Iquitos experiencing recurrent outbreaks and limited control options.
Jorge L Cañari-Casaño +9 more
doaj +2 more sources
Current Dengue Virus Vaccine Developments and Future Directions
VirusesDengue fever (DF), a leading arboviral disease globally, is caused by the Dengue virus (DENV) and represents a significant public health concern, with an estimated 390 million cases reported annually.
Govindaraj Anumanthan +2 more
doaj +3 more sources
Advancing dengue vaccine development: Challenges, innovations, and the path toward global protection [PDF]
Pediatric InvestigationDengue fever remains a significant global health threat, placing nearly half of the world's population at risk. Despite decades of research, developing an effective dengue vaccine continues to face multiple challenges, including antibody‐dependent ...
Ran Wang +3 more
doaj +2 more sources
BMC Infectious Diseases, 2020 Background Dengue fever is a major public health problem in Colombia. A fever surveillance study was conducted for evaluation of the clinical, epidemiological, and molecular patterns of dengue, prior to Chikungunya and Zika epidemics. Methods In November
Jacqueline Kyungah Lim +8 more
doaj +1 more source
Is new dengue vaccine efficacy data a relief or cause for concern?
npj Vaccines, 2023 Dengue is a major global public health problem requiring a safe and efficacious vaccine as the foundation of a comprehensive countermeasure strategy. Despite decades of attempts, the world has a single dengue vaccine licensed in numerous countries, but ...
Stephen J. Thomas
doaj +1 more source
Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. [PDF]
PLoS Pathogens, 2013 With 2.5 billion people at risk, dengue is a major emerging disease threat and an escalating public health problem worldwide. Dengue virus causes disease ranging from a self-limiting febrile illness (dengue fever) to the potentially fatal dengue ...
Raphaël M Zellweger +5 more
doaj +1 more source
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement. [PDF]
PLoS Neglected Tropical Diseases, 2013 BACKGROUND: Dengue virus is a mosquito-transmitted virus that can cause self-limiting dengue fever, severe life-threatening dengue hemorrhagic fever and dengue shock syndrome.
Chen-Yi Chiang +9 more
doaj +1 more source
BMC Public Health, 2022 Background Dengue vaccine is a promising alternative for protecting communities from dengue. Nevertheless, public acceptance of the dengue vaccine must be considered before the authorities decide to carry out intensified research and recommend the ...
Ahmad Firdhaus Arham +6 more
doaj +1 more source